Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRent ExpenseRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

National Healthcare Properties (HLTC) Consolidated Net Income (2016 - 2025)

National Healthcare Properties has reported Consolidated Net Income over the past 13 years, most recently at -$22.8 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income fell 33.94% year-over-year to -$22.8 million; the TTM value through Dec 2025 reached -$57.7 million, up 69.68%, while the annual FY2025 figure was -$57.7 million, 69.68% up from the prior year.
  • Consolidated Net Income for Q4 2025 was -$22.8 million at National Healthcare Properties, down from -$12.5 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at -$1.5 million in Q1 2025 and troughed at -$116.9 million in Q2 2024.
  • A 5-year average of -$24.3 million and a median of -$18.2 million in 2022 define the central range for Consolidated Net Income.
  • Biggest five-year swings in Consolidated Net Income: tumbled 574.58% in 2024 and later skyrocketed 90.26% in 2025.
  • Year by year, Consolidated Net Income stood at -$19.4 million in 2021, then grew by 3.7% to -$18.7 million in 2022, then plummeted by 32.84% to -$24.9 million in 2023, then surged by 31.5% to -$17.0 million in 2024, then tumbled by 33.94% to -$22.8 million in 2025.
  • Business Quant data shows Consolidated Net Income for HLTC at -$22.8 million in Q4 2025, -$12.5 million in Q3 2025, and -$20.8 million in Q2 2025.